EnVVeno Medical Total Current Liabilities 2017-2025 | NVNO
EnVVeno Medical Annual Total Current Liabilities (Millions of US $) |
|
---|---|
2024 | $2 |
2023 | $1 |
2022 | $2 |
2021 | $2 |
2020 | $3 |
2019 | $2 |
2018 | $2 |
2017 | $3 |
2016 | $1 |
EnVVeno Medical Quarterly Total Current Liabilities (Millions of US $) |
|
---|---|
2025-03-31 | $2 |
2024-12-31 | $2 |
2024-09-30 | $2 |
2024-06-30 | $2 |
2024-03-31 | $1 |
2023-12-31 | $1 |
2023-09-30 | $2 |
2023-06-30 | $2 |
2023-03-31 | $1 |
2022-12-31 | $2 |
2022-09-30 | $1 |
2022-06-30 | $2 |
2022-03-31 | $1 |
2021-12-31 | $2 |
2021-09-30 | $1 |
2021-06-30 | $1 |
2021-03-31 | $2 |
2020-12-31 | $3 |
2020-09-30 | $2 |
2020-06-30 | $3 |
2020-03-31 | $2 |
2019-12-31 | $2 |
2019-09-30 | $2 |
2019-06-30 | $2 |
2019-03-31 | $2 |
2018-12-31 | $2 |
2018-09-30 | $2 |
2018-06-30 | $3 |
2018-03-31 | $2 |
2017-12-31 | $3 |
2017-09-30 | |
2017-06-30 | |
2017-03-31 | |
2016-12-31 | $1 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED INSTRUMENTS | $0.058B | $0.000B |
enVVeno Medical Corporation is a medical device company. It focuses in the treatment of venous disease. enVVeno Medical Corporation, formerly known as Hancock Jaffe Laboratories Inc., is based in IRVINE, CA. |